Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
van Houte Hans
Chief Financial Officer at Nurix Therapeutics. Filing since 18 Feb 2021.
CIK 0001817217
Company
Date
Role
Action
Shares
Amount
Of holding
NRIX
Nurix Therapeutics, Inc.
4 Aug 2026
Chief Financial Officer
Sold on a plan
4,761
$115.99K
10.6%
NRIX
Nurix Therapeutics, Inc.
30 Jul 2026
Chief Financial Officer
Sold at will
2,845
$66.52K
6.0%
NRIX
Nurix Therapeutics, Inc.
5 May 2026
Chief Financial Officer
Sold on a plan
14,055
$233.32K
27.2%
NRIX
Nurix Therapeutics, Inc.
30 Apr 2026
Chief Financial Officer
Sold at will
2,388
$39.75K
4.4%
NRIX
Nurix Therapeutics, Inc.
30 Jan 2026
Chief Financial Officer
Sold at will
3,661
$60.77K
7.5%
NRIX
Nurix Therapeutics, Inc.
3 Nov 2025
Chief Financial Officer
Sold on a plan
6,284
$78.93K
14.3%
NRIX
Nurix Therapeutics, Inc.
30 Oct 2025
Chief Financial Officer
Sold at will
3,130
$40.05K
6.7%
NRIX
Nurix Therapeutics, Inc.
1 Aug 2025
Chief Financial Officer
Sold on a plan
5,402
$59.60K
13.2%
NRIX
Nurix Therapeutics, Inc.
30 Jul 2025
Chief Financial Officer
Sold at will
4,304
$51.70K
9.5%
NRIX
Nurix Therapeutics, Inc.
2 May 2025
Chief Financial Officer
Sold on a plan
6,198
$70.24K
15.5%
NRIX
Nurix Therapeutics, Inc.
30 Apr 2025
Chief Financial Officer
Sold at will
2,438
$28.04K
5.8%
NRIX
Nurix Therapeutics, Inc.
3 Mar 2025
Chief Financial Officer
Sold on a plan
5,825
$84.39K
14.7%
NRIX
Nurix Therapeutics, Inc.
30 Jan 2025
Chief Financial Officer
Sold at will
2,811
$55.81K
6.6%
NRIX
Nurix Therapeutics, Inc.
1 Nov 2024
Chief Financial Officer
Sold on a plan
3,546
$86.08K
9.5%
NRIX
Nurix Therapeutics, Inc.
30 Oct 2024
Chief Financial Officer
Sold at will
2,368
$57.55K
6.0%
NRIX
Nurix Therapeutics, Inc.
26 Aug 2024
Chief Financial Officer
Sold on a plan
20,000
$504.37K
39.2%
NRIX
Nurix Therapeutics, Inc.
1 Aug 2024
Chief Financial Officer
Sold on a plan
3,477
$74.58K
6.4%
NRIX
Nurix Therapeutics, Inc.
30 Jul 2024
Chief Financial Officer
Sold at will
2,490
$51.46K
4.4%
NRIX
Nurix Therapeutics, Inc.
20 Jun 2024
Chief Financial Officer
Sold on a plan
20,000
$400.22K
29.3%
NRIX
Nurix Therapeutics, Inc.
2 May 2024
Chief Financial Officer
Sold on a plan
3,499
$44.88K
4.9%
NRIX
Nurix Therapeutics, Inc.
30 Apr 2024
Chief Financial Officer
Sold at will
1,387
$16.70K
1.9%
NRIX
Nurix Therapeutics, Inc.
16 Feb 2024
Chief Financial Officer
Sold on a plan
6,812
$68.22K
9.1%
NRIX
Nurix Therapeutics, Inc.
30 Jan 2024
Chief Financial Officer
Sold at will
1,671
$13.35K
2.2%
NRIX
Nurix Therapeutics, Inc.
20 Dec 2023
Chief Financial Officer
Sold on a plan
3,541
$35.42K
4.7%
NRIX
Nurix Therapeutics, Inc.
19 Dec 2023
Chief Financial Officer
Sold on a plan
10,906
$109.09K
12.6%
NRIX
Nurix Therapeutics, Inc.
31 Oct 2023
Chief Financial Officer
Sold at will
1,080
$5.61K
1.2%
NRIX
Nurix Therapeutics, Inc.
31 Jul 2023
Chief Financial Officer
Sold at will
1,245
$12.02K
1.5%
NRIX
Nurix Therapeutics, Inc.
1 May 2023
Chief Financial Officer
Sold at will
721
$7.12K
0.9%
NRIX
Nurix Therapeutics, Inc.
30 Jan 2023
Chief Financial Officer
Sold, plan not stated
924
$10.88K
1.2%
NRIX
Nurix Therapeutics, Inc.
31 Oct 2022
Chief Financial Officer
Sold, plan not stated
739
$9.52K
1.0%
NRIX
Nurix Therapeutics, Inc.
1 Aug 2022
Chief Financial Officer
Sold, plan not stated
752
$11.78K
1.0%
NRIX
Nurix Therapeutics, Inc.
2 May 2022
Chief Financial Officer
Sold, plan not stated
697
$8.19K
24.2%
NRIX
Nurix Therapeutics, Inc.
24 Feb 2021
Chief Financial Officer
Sold, plan not stated
35,419
$1.41M
100%
NRIX
Nurix Therapeutics, Inc.
22 Feb 2021
Chief Financial Officer
Sold, plan not stated
5,330
$212.84K
100%
NRIX
Nurix Therapeutics, Inc.
18 Feb 2021
Chief Financial Officer
Sold, plan not stated
13,583
$481.62K
100%
35 decisions on file.
